PMID: 39313Jun 28, 1979

Benzodiazepines alter acquisition and retention of an inhibitory avoidance response in mice

R A JensenJ L McGaugh


These experiments were performed to examine the effects of graded doses of diazepam, flurazepam, or lorazepam given to Swiss-Webster mice either 30 min prior to training or immediately after training in a one-trial inhibitory (passive) avoidance task. A 350 MUA footshock was administered following entry into a darkened compartment and retention was tested three days later. Doses of 10.0 mg/kg diazepam and 20.0 mg/kg lorazepam given before training significantly impaired acquisition, while 1.0 mg/kg flurazepam, given immediately after training, produced retrograde amnesia. These results indicate that benzodiazepines affect memory processes and that various drugs of the benzodiazepine family differentially affect acquisition and memory consolidation.


May 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·A BeckerH Matthies
Jan 1, 1985·Psychopharmacology·D J Sanger, D Joly
Jun 26, 2012·Psychopharmacology·Karina A ZaninRoberto Frussa-Filho
Aug 31, 1987·Life Sciences·M S HuangS B Sparber
Oct 1, 1996·Physiology & Behavior·L J Wichlinski, R A Jensen
Mar 1, 1996·Pharmacology, Biochemistry, and Behavior·M P Clements, R C Bourne
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·M H Thiébot
Jan 1, 1986·Neuroscience and Biobehavioral Reviews·S O Cole
Jul 1, 1993·Behavioral and Neural Biology·H Dickinson-Anson, J L McGaugh
Jan 1, 1987·Pharmacology & Therapeutics·S E File, S Pellow
Jul 1, 1991·Trends in Pharmacological Sciences·I Izquierdo, J H Medina
Jan 1, 1981·Progress in Neuro-psychopharmacology·M D Morris, G F Gebhart
Jun 1, 1996·Brain Research. Cognitive Brain Research·J C Bizot, M H Thiébot
Jun 12, 2003·Behavioural Brain Research·Manish Kumar SarafManjeet Singh
Aug 1, 1984·Psychological Medicine·C E Giurgea
Aug 21, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael DavisChristian Grillon
Dec 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Naoe OkamuraRainer K Reinscheid
Apr 23, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Steve R MakkarJacquelyn Cranney
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C TomazJ L McGaugh
Dec 3, 2005·Learning & Memory·Georgette M GaffordFred J Helmstetter
Dec 1, 1982·Journal of Pharmacological Methods·S BanfiL Dorigotti
Jan 19, 2016·Frontiers in Behavioral Neuroscience·Daniela R de OliveiraSuzete M Cerutti
Jul 9, 2011·Neuropharmacology·Thomas Steckler, Victoria Risbrough
Sep 29, 2004·The European Journal of Neuroscience·H WanM W Brown
Jan 1, 1983·Pharmacological Research Communications·A FundaròL Molinengo
Mar 18, 2006·Neuroscience·S G BustosV A Molina
Jan 1, 1990·Neuroscience and Biobehavioral Reviews·I IzquierdoJ H Medina
Jun 7, 2011·Pharmacology, Biochemistry, and Behavior·Russell J AmatoPeter J Winsauer


Aug 25, 1972·Annals of the New York Academy of Sciences·J L McGaugh
Feb 1, 1972·Physiology & Behavior·S F Zornetzer, J L McGaugh
Jan 1, 1972·British Journal of Pharmacology·J W Dundee, S K Pandit
Jun 30, 1972·Science
Aug 1, 1967·Psychological Reports·M E Jarvik, R Kopp

Related Concepts

Avoidance Learning
Anti-Anxiety Effect
Retention (Psychology)
Retrograde Amnesia

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.